Solid Capital Surpluse from 2010 to 2024
| SLDB Stock | USD 10.37 0.12 1.17% |
Capital Surpluse | First Reported 2010-12-31 | Previous Quarter 890.6 M | Current Value 597.6 M | Quarterly Volatility 194.4 M |
Check Solid Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Solid main balance sheet or income statement drivers, such as Interest Income of 7.4 M, Interest Expense of 24.7 M or Selling General Administrative of 20.8 M, as well as many exotic indicators such as Price To Sales Ratio of 10.66, Dividend Yield of 0.0 or PTB Ratio of 1.01. Solid financial statements analysis is a perfect complement when working with Solid Biosciences Valuation or Volatility modules.
Solid | Capital Surpluse |
Latest Solid Biosciences' Capital Surpluse Growth Pattern
Below is the plot of the Capital Surpluse of Solid Biosciences LLC over the last few years. It is Solid Biosciences' Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Solid Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Capital Surpluse | 10 Years Trend |
|
Capital Surpluse |
| Timeline |
Solid Capital Surpluse Regression Statistics
| Arithmetic Mean | 453,220,637 | |
| Geometric Mean | 421,747,171 | |
| Coefficient Of Variation | 42.89 | |
| Mean Deviation | 162,406,316 | |
| Median | 324,209,000 | |
| Standard Deviation | 194,388,583 | |
| Sample Variance | 37786.9T | |
| Range | 566.4M | |
| R-Value | 0.80 | |
| Mean Square Error | 14376.4T | |
| R-Squared | 0.65 | |
| Significance | 0.0003 | |
| Slope | 34,955,243 | |
| Total Sum of Squares | 529016.9T |
Solid Capital Surpluse History
About Solid Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Solid Biosciences income statement, its balance sheet, and the statement of cash flows. Solid Biosciences investors use historical funamental indicators, such as Solid Biosciences's Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Solid Biosciences investors may use each financial statement separately, they are all related. The changes in Solid Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Solid Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Solid Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Solid Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Surpluse | 890.6 M | 597.6 M |
Currently Active Assets on Macroaxis
When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:Check out the analysis of Solid Biosciences Correlation against competitors. Note that the Solid Biosciences LLC information on this page should be used as a complementary analysis to other Solid Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Solid Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.83) | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.57) |
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.